A breakthrough in preparing malaria vaccines

On July 2, Australian scientists announced an arson step during the preparation of a malaria vaccine.

Test results on mice show that this vaccine works to protect them from the germs that cause malaria.

The researchers tested a drug that could block the replication of malaria parasites and create "strong immunity" in mice after being injected into mice.

Scientist Michael Good of Griffith University, co-author of the study, said his team focused on white blood cells, or T cells, to attack them. Malaria parasites often "hide" in red blood cells. When stimulated to kill malaria parasites, white blood cells are able to identify proteins inside the parasite.

According to Good, this new finding allows scientists to develop an immune form that can identify hidden molecules in parasites that cause disease in different strains of malaria.

After the experiment in mice, the authors will conduct a new vaccine in the human body. If successful, this vaccine will be a great support for poor countries in the fight against malaria because of its reasonable price and more convenient production.

According to the World Health Organization (WHO), an estimated half of the world's population, equivalent to 3.3 billion people at risk of malaria.

Since 2000, the international community and countries around the world have stepped up the implementation of malaria control and prevention measures to reduce mortality to 25%, but in 2010, there are 219 million cases of disease were discovered, of which 600,000 died.